-
Jun 13, 2022, 5:27 pm247 pts
Mugglehead
Cannabinoid manufacturer InMed Pharmaceuticals Inc. (Nasdaq: INM) will be launching B2B sales of delta 9-dominant tetrahydrocannabivarin (d9-THCV). On Thursday, the pharmaceutical said the rare cannabinoid may look similar to THC, but it does not have the same psychoactive properties. However, THCV is found…
Trending Today on NewsBudz
NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.
Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.
Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.
